- Home
- USAS vs RPTX Comparison
USAS vs RPTX Comparison
Compare USAS & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- RPTX
- Stock Information
- Founded
- USAS 1998
- RPTX 2016
- Country
- USAS Canada
- RPTX Canada
- Employees
- USAS N/A
- RPTX N/A
- Industry
- USAS Metal Mining
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- RPTX Health Care
- Exchange
- USAS Nasdaq
- RPTX Nasdaq
- Market Cap
- USAS 122.4M
- RPTX 141.1M
- IPO Year
- USAS N/A
- RPTX 2020
- Fundamental
- Price
- USAS $0.40
- RPTX $1.32
- Analyst Decision
- USAS Strong Buy
- RPTX Strong Buy
- Analyst Count
- USAS 1
- RPTX 3
- Target Price
- USAS $0.80
- RPTX $7.00
- AVG Volume (30 Days)
- USAS 714.8K
- RPTX 709.5K
- Earning Date
- USAS 11-07-2024
- RPTX 11-07-2024
- Dividend Yield
- USAS N/A
- RPTX N/A
- EPS Growth
- USAS N/A
- RPTX N/A
- EPS
- USAS N/A
- RPTX N/A
- Revenue
- USAS $97,123,000.00
- RPTX $66,524,000.00
- Revenue This Year
- USAS $21.84
- RPTX $13.22
- Revenue Next Year
- USAS $46.00
- RPTX N/A
- P/E Ratio
- USAS N/A
- RPTX N/A
- Revenue Growth
- USAS 14.33
- RPTX 18.19
- 52 Week Low
- USAS $0.20
- RPTX $1.23
- 52 Week High
- USAS $0.54
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- USAS 52.20
- RPTX 30.27
- Support Level
- USAS $0.35
- RPTX $1.23
- Resistance Level
- USAS $0.44
- RPTX $4.07
- Average True Range (ATR)
- USAS 0.03
- RPTX 0.34
- MACD
- USAS -0.00
- RPTX -0.20
- Stochastic Oscillator
- USAS 60.00
- RPTX 3.34
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.